Sinha, Shubhadeep D.
Bandi, Vamsi Krishna
Bheemareddy, Bala Reddy
Thakur, Pankaj
Chary, Sreenivasa
Mehta, Kalpana
Pinnamareddy, Vikranth Reddy
Pandey, Rajendra
Sreepada, Subhramanyam
Durugkar, Santosh
Article History
Received: 23 October 2018
Accepted: 11 January 2019
First Online: 13 March 2019
Change Date: 19 November 2019
Change Type: Correction
Change Details: Following publication of the original article [1], the authors reported errors in the presentation of Tables 2, 4 and 5.
Ethics approval and consent to participate
: The study was conducted in accordance with the ethical guidelines outlined in the Declaration of Helsinki, 1964 as revised in 2013. Institutional ethics committee approval was obtained (details given in the Additional file InternalRef removed: Table S1) from each participating study center before initiating the study. Prior to conducting any study-related screening procedure, written informed consent was obtained from each patient before enrolling them in the study. The study was registered with the clinical trial registry (CTRI: CTRI/2012/07/002835) prior to any enrollment.
: Not applicable.
: SS1, VB, BB, PT and SC are the employees of Hetero Biopharma Limited, India and involved from conception of study to the approval of the manuscript. All the authors declare no other competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.